IVF MEXC RealStocks
Own real IVF shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-17 20:56:00. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
INVO Fertility, Inc. (IVF) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $2.17, with a market capitalization of $3.10M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.59 to $91.60. This page covers its latest market performance, valuation, price trends and company information.
$3.10M | |
$2.35 | |
$2.38 | |
$2.17 | |
$2.40 | |
46.42K | |
62.23K | |
-- | |
$91.60 | |
$1.59 | |
-- | |
-- |
INVO Fertility, Inc. (IVF) is currently trading at $2.17 as of 2026-11-17 20:55:00, down 7.66% ($0.18) from the previous close of $2.40
During today's regular trading session, IVF has traded between $2.17 and $2.38, with a trading volume of 46.42K shares. The current price is near the lower end of today's range.
Over the past seven days, INVO Fertility, Inc. (IVF) moved from $2.14 to $2.17, representing a gain of 1.40% ($0.03).
The stock traded between $1.95 and $2.78 during the period. The latest price is near the lower end of the 7-day range, indicating moderate upward.
The average daily volume was 38.13 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 0.6%
IVF is currently trading at $2.17, placing it 0.6% of the way from its 52-week low of $1.59 to its 52-week high of $91.60. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
INVO Fertility Inc is a healthcare services fertility company dedicated to expanding assisted reproductive technology (ART) care to patients in need. It is offering the intravaginal culture (IVC) procedure enabled by INVOcell medical device (INVOcell). The INVOcell is a proprietary and revolutionary medical device, and the first to allow fertilization and early embryo development to take place in vivo within the woman's body. The company's segments include: The Clinics Services operating segment consisting of financial information for WFI and the Atlanta Clinic and The INVOcell Device operating segment consisting of financial information relating to the manufacture and sales of the INVOcell.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 46 |
| Exchange | NASDAQ |
| Company Website |
View the latest dividend and stock split events for INVO Fertility, Inc.
Stock Split | |
|---|---|
| Split Date | 30 Oct 2026 |
| Split Ratio | 1-for-4 |
Eligible investors can buy real shares of INVO Fertility, Inc. (IVF) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to IVF, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between IVF shares and USD.
IVF Shares to USD
1.00 IVF shares = 2.17 USD
Calculations are estimates based on the latest available price and are for reference only.